Hippocrates Ventures

Overview

Hippocrates Ventures is a physician-funded venture capital firm dedicated to investing in healthcare and life sciences companies that aim to enhance patient outcomes and drive medical innovation. The firm focuses on sectors such as biopharmaceuticals, diagnostics, medical devices, and digital health, seeking to support companies with cutting-edge technologies and solutions. By leveraging the expertise and networks of its physician investors, Hippocrates Ventures aims to identify and nurture high-potential startups that can make a significant impact in the healthcare industry. The firm's investment strategy is opportunistic, targeting companies with the greatest medium and long-term growth potential. Hippocrates Ventures takes a global, research-intensive approach to allocating investments, aiming to invest specifically in cutting-edge and undervalued companies. The management team comprises physicians, scientists, and industry experts with deep scientific and clinical knowledge, as well as diverse skills ranging from operating experience to legal and financial expertise. This diverse team enables the firm to assess investment opportunities comprehensively and execute strategic investments effectively. Hippocrates Ventures' portfolio includes companies like Smiley Scope, which offers evidence-based digital therapeutics to transform patient outcomes, Avive AED, striving to increase survival rates for sudden cardiac arrest, and Fruit Street, delivering the CDC's diabetes prevention program through telehealth and live group video conferencing with registered dietitians. These investments reflect the firm's commitment to supporting innovative solutions that address critical challenges in healthcare and life sciences, ultimately aiming to improve patient care and advance medical practices.